Ovarian and Breast cancer rising among younger women

Ovarian and Breast cancer rising among younger women 

Dr Divesh Goyal, Senior Consultant, Oncology, Fortis Escorts Hospital Jaipur 

 Jaipur_02nd Feb 2026, In recent years, India has witnessed a troubling shift in cancer patterns among women. Breast and ovarian cancers — once considered predominantly diseases of older age — are now increasingly being diagnosed in younger women. This trend has serious implications for public health, highlighting gaps in awareness, early detection, and preventive care. It demands urgent action from healthcare professionals, policymakers, and communities alike. In India, cancer is no longer a distant or rare illness. Around 2.5 million people are living with the disease today. Every year, more than 7 lakh new cases are added, and over 5.5 lakh lives are lost. What often goes unnoticed is that most of these deaths occur in people between 30 and 69 years of age. These are productive years, when individuals are building families, careers, and futures. When cancer strikes at this stage, its impact ripples far beyond the patient. 

Breast cancer remains the most commonly diagnosed cancer among women in India. According to the latest data from the Global Cancer Observatory (GLOBOCAN), an estimated 178,361 new breast cancer cases were reported in India in 2020, accounting for nearly 30% of all female cancers. Alarming evidence shows that a growing number of these cases are occurring in women under the age of 40 — a demographic traditionally considered at low risk. Early-onset breast cancer often presents more aggressively, tends to have poorer outcomes, and significantly disrupts women’s personal and professional lives. 

Similarly, ovarian cancer - the third most common gynecological cancer in India after cervical and corpus uteri cancers - is showing an upward trend among younger women. National estimates indicate approximately 47,000 new ovarian cancer cases each year, with thousands of fatalities. While the highest incidence is still observed in women over 50, recent clinic-based studies and hospital reports suggest that women in their 20s and 30s are increasingly being diagnosed, often at advanced stages. 

Several factors are believed to contribute to this shift. Modern lifestyle changes - including reduced breastfeeding duration, sedentary habits, and rising obesity - have been linked to increased breast and ovarian cancer risks. Additionally, conditions such as polycystic ovarian  syndrome (PCOS), common among young women, may contribute to hormonal imbalances that elevate cancer risk. Genetic predispositions, including BRCA1 and BRCA2 mutations, also play a significant role, particularly in early-onset breast and ovarian cancers. 

Despite these alarming trends, awareness and screening remain inadequate. A large proportion of young women are unaware of basic warning signs, such as breast lumps, changes in breast shape, persistent abdominal bloating, or unexplained pelvic pain. Self-breast examination, a simple and cost-effective first step in early detection, is practiced by a minority of women. Meanwhile, no widely accessible screening protocol exists for ovarian cancer, making early diagnosis challenging. 

The consequences of late diagnosis are severe. Advanced breast and ovarian cancers are harder to treat, require intensive therapies, and often result in lower survival rates. Young women diagnosed with these cancers face unique challenges, including fertility concerns, psychological distress, and disruptions to career and family life. These impacts underscore the need for targeted support systems and comprehensive care pathways. 

Addressing this growing public health crisis requires a multi-pronged approach. First, Public education campaigns must be intensified to raise awareness about symptoms, risk factors, and the importance of early detection. Schools, colleges, workplaces, and community groups should be engaged as platforms for cancer literacy. Second, healthcare systems must expand screening services and diagnostic access, particularly in underserved areas. Mobile health units, subsidized mammography, and clinical breast examinations can bridge critical gaps in early detection. 

Genetic counseling and testing should be promoted for high-risk individuals, while research into culturally appropriate prevention strategies must be prioritized. Importantly, emotional and psychosocial support services should be integrated into cancer care for young women, helping them navigate treatment, survivorship, and quality-of-life issues. 

Breast and ovarian cancers are not inevitable — many cases can be detected early and treated successfully. Recognizing the rising incidence among young women is the first step toward reversing this dangerous trend. Through awareness, education, and strengthened healthcare responses, we can protect the health and futures of India’s young women.